These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18569637)

  • 21. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
    Hess CJ; Ameziane N; Schuurhuis GJ; Errami A; Denkers F; Kaspers GJ; Cloos J; Joenje H; Reinhardt D; Ossenkoppele GJ; Zwaan CM; Waisfisz Q
    Cell Oncol; 2008; 30(4):299-306. PubMed ID: 18607065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
    Sheng X; Guo Y; Lu Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry.
    Trabelsi S; Mama N; Ladib M; Karmeni N; Haddaji Mastouri M; Chourabi M; Mokni M; Tlili K; Krifa H; Yacoubi MT; Saad A; H'mida Ben Brahim D
    Clin Transl Oncol; 2016 Apr; 18(4):391-7. PubMed ID: 26289551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia.
    Agrawal S; Hofmann WK; Tidow N; Ehrich M; van den Boom D; Koschmieder S; Berdel WE; Serve H; Müller-Tidow C
    Blood; 2007 May; 109(9):3895-905. PubMed ID: 17234736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis.
    Teofili L; Martini M; Luongo M; Diverio D; Capelli G; Breccia M; Lo Coco F; Leone G; Larocca LM
    Leukemia; 2003 May; 17(5):919-24. PubMed ID: 12750706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours.
    Agundez M; Grau L; Palou J; Algaba F; Villavicencio H; Sanchez-Carbayo M
    Eur Urol; 2011 Jul; 60(1):131-40. PubMed ID: 21514719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
    Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
    J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
    Melki JR; Vincent PC; Clark SJ
    Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease.
    Pesek M; Kopeckova M; Benesova L; Meszarosova A; Mukensnabl P; Bruha F; Minarik M
    Anticancer Res; 2011 Dec; 31(12):4647-52. PubMed ID: 22199344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
    Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
    Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients.
    Dodge JE; Munson C; List AF
    Leuk Res; 2001 Oct; 25(10):917-25. PubMed ID: 11532526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status.
    Bueso-Ramos C; Xu Y; McDonnell TJ; Brisbay S; Pierce S; Kantarjian H; Rosner G; Garcia-Manero G
    J Clin Oncol; 2005 Jun; 23(17):3932-9. PubMed ID: 15851765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
    Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.